Enter your login e-mail to the account
Search
Search parameters
Search results
- Use of biological treatment in oncology
MUDr. Michal Mego, MUDr. Lucia Masárová
(6/2011, Review articles )
- The use of monoclonal antibodies in neurology
prof. MUDr. Egon Kurča, PhD., MUDr. Mária Cuninková
(6/2011, Main topic )
- Targeted biological therapy for lung cancer – current status and perspectives
doc. MUDr. Peter Beržinec, CSc.
(1/2011, Review articles ) - Biological treatment of the small cell lung cancer
MUDr. Peter Kasan
(1/2007, Review articles ) - Adjuvant therapy of colorectal cancer in elderly patients
doc. MUDr. Mária Wagnerová, CSc., doc. MUDr. Alexander Berč, CSc.
(4/2007, Review articles ) - Patient registries – a need for real data in the context of efficacy, safety and cost effectiveness
PharmDr. Dominik Tomek, MPH, RNDr. Mária Pšenková, Ing. Branislav Balvan
(2/2010, Review articles ) - Pneumotoxicity of molecularly targeted anticancer drugs
doc. MUDr. Peter Beržinec, CSc.
(1/2013, Main topic ) - Cetuximab – a chimeric monoclonal IgG1 antibody for the treatment of patients with squamous cell cancer of the head and neck
doc. PharmDr. Juraj Sýkora, CSc.
(6/2009, Drugs & drug classes ) - Financial expenditures in the context of pharmacotherapy of oncological diseases
doc. PharmDr. Tomáš Tesař, PhD., MBA, PhDr. Ľubica Hlinková, MPH
(1/2014, Main topic ) - The combination of cetuximab and radiotherapy in the first line treatment of colorectal carcinoma – The Slovak project
MUDr. Tomáš Šálek, MUDr. Marián Streško, MUDr. Jozef Chovanec, MUDr. Eduard Šebo, MUDr. Dagmar Mazalová, MUDr. Alena Thomková, a ďalší
(5/2010, Original articles & case reports ) - BIOPHARMACEUTICALS IN ONCOLOGY
doc. PharmDr. Juraj Sýkora, CSc.
(3/2008, Review articles ) - Monoclonal antibodies in antitumorous therapy and infectious complications
MUDr. Ľuboš Drgoňa, CSc.
(6/2010, Review articles ) - ERBITUX®: cielená blokáda egfr zvyšuje účinnosť liečby
MUDr. Lenka Slanináková
(1/2006, Review articles ) - DID THE INTRODUCTION OF TARGETED THERAPY LIMIT THE IMPORTANCE OF CYTOSTATIC TREATMENT ?
prof. MUDr. Pavel Klener, DrSc.
(6/2007, Review articles ) - NOVÁ PRVOLÍNIOVÁ LIEČBA METASTATICKÉHO KOLOREKTÁLNEHO KARCINÓMU 4TH TH CRC EGFR SYMPÓZIUM, BARCELONA 24. 6. 2008
MUDr. Marián Streško
(4/2008, Events ) - CHEMOTHERAPY OF THE HEAD AND NECK TUMOR´S
MUDr. Dagmar Sorkovská
(3/2007, Review articles - treatment ) - COMPLETE REMISION AFTER CETUXIMAB WITH IRINOTECAN IN COMBINATION WITH SURGICAL TREATMENT IN PRETREATED PATIENT (CASE REPORT)
MUDr. Jozef Šufliarsky
(3/2007, Original articles )
- CHEMOTHERAPY OF THE HEAD AND NECK TUMOR´S
MUDr. Dagmar Sorkovská
(3-4/2007, clearly )